Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugs.

MLA

Susan M. Chang, et al. “Phase I/Pharmacokinetic Study of CCI-779 in Patients with Recurrent Malignant Glioma on Enzyme-Inducing Antiepileptic Drugs.” Investigational New Drugs, vol. 22, no. 4, Nov. 2004, pp. 427–35. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=22129396&authtype=sso&custid=ns315887.

APA

Susan M. Chang, John Kuhn, & Patrick Wen. (2004). Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugs. Investigational New Drugs, 22(4), 427–435.

Chicago

Susan M. Chang, John Kuhn, and Patrick Wen. 2004. “Phase I/Pharmacokinetic Study of CCI-779 in Patients with Recurrent Malignant Glioma on Enzyme-Inducing Antiepileptic Drugs.” Investigational New Drugs 22 (4): 427–35. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=22129396&authtype=sso&custid=ns315887.